A detailed history of Cinctive Capital Management LP transactions in Incyte Corp stock. As of the latest transaction made, Cinctive Capital Management LP holds 80,450 shares of INCY stock, worth $5.48 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
80,450
Holding current value
$5.48 Million
% of portfolio
0.3%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$65.08 - $83.38 $5.24 Million - $6.71 Million
80,450 New
80,450 $5.56 Million
Q1 2023

May 15, 2023

BUY
$70.23 - $86.01 $329,308 - $403,300
4,689 New
4,689 $338,000
Q2 2022

Aug 15, 2022

SELL
$66.18 - $83.18 $1.65 Million - $2.08 Million
-25,000 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$66.02 - $79.71 $1.65 Million - $1.99 Million
25,000 New
25,000 $1.99 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.1B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Cinctive Capital Management LP Portfolio

Follow Cinctive Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Cinctive Capital Management LP with notifications on news.